Clinical Research Site

Toronto, Ontario M6G2N2

1 studies enrolling now · 5 studies all time

What they study most

Cataplexy, Excessive Daytime Sleepiness, Excessive Sleepiness, Hidradenitis Suppurativa, Narcolepsy, Refractory IPA, Shift-work Disorder

Studies at this site

• Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) — Recruiting now
• A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy — Completed
• Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study) — Stopped early
• A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE) — Completed
• Hidradenitis Suppurativa Study of Izokibep — Stopped early